CHIP studies have identified a high prevalence of gene mutations that overlap with those found in overt hematological malignancies such as MDS, AML, and chronic myeloid leukemia (CML). The gene discussed is STUB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.